Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Petracci

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Statistics & Probability Letters|June 7, 2011
Variance computations for functional of absolute risk estimatesR M Pfeiffer, E Petracci
Breast Cancer : Basic and Clinical Research|August 28, 2023
Hormone Receptor-Positive / HER2-Negative Early Breast Cancer High-Risk Population: An Algorithm for Optimization Systemic Adjuvant Treatment Based on 2022 UpdatesDaniel González-Hurtado, Sergio Rivero, Juan Carlos Samamé Pérez-Vargas, et al.
Journal of Biomechanics|February 4, 2014
Prediction bands and intervals for the scapulo-humeral coordination based on the Bootstrap and two Gaussian methodsA G Cutti, I Parel, M Raggi, et al.
Ecancermedicalscience|November 21, 2022
Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2Dana Narváez, Federico Waisberg, Tomás Soulé, et al.
Journal of Human Hypertension|July 6, 2007
Adherence to antihypertensive drug treatment and blood pressure control: a real practice analysis in ItalyM Di Martino, C Veronesi, L Degli Esposti, et al.
Neurology|August 8, 2007
Neuropathy in multiple myeloma treated with thalidomide: a prospective studyR Plasmati, F Pastorelli, M Cavo, et al.
Ecancermedicalscience|February 28, 2024
<i>LuciA-15</i> - a real-world prospective study of PARP inhibitors for the treatment of patients with HER-2 negative metastatic breast cancer with germline and/or somatic mutation of BRCA genes or homologous recombination repair related genesFernando E Petracci, Cynthia Villarreal-Garza, Facundo Argañaraz, et al.
Cancers|January 23, 2024
The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative ReviewDana Narvaez, Jorge Nadal, Adrian Nervo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2016
Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG studyL Capelli, E Petracci, V Quagliuolo, et al.
ESMO Open|April 25, 2025
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trialG Schepisi, M Urbini, C Casadei, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Statistics & Probability Letters|June 7, 2011
Variance computations for functional of absolute risk estimatesR M Pfeiffer, E Petracci
Breast Cancer : Basic and Clinical Research|August 28, 2023
Hormone Receptor-Positive / HER2-Negative Early Breast Cancer High-Risk Population: An Algorithm for Optimization Systemic Adjuvant Treatment Based on 2022 UpdatesDaniel González-Hurtado, Sergio Rivero, Juan Carlos Samamé Pérez-Vargas, et al.
Journal of Biomechanics|February 4, 2014
Prediction bands and intervals for the scapulo-humeral coordination based on the Bootstrap and two Gaussian methodsA G Cutti, I Parel, M Raggi, et al.
Ecancermedicalscience|November 21, 2022
Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2Dana Narváez, Federico Waisberg, Tomás Soulé, et al.
Journal of Human Hypertension|July 6, 2007
Adherence to antihypertensive drug treatment and blood pressure control: a real practice analysis in ItalyM Di Martino, C Veronesi, L Degli Esposti, et al.
Neurology|August 8, 2007
Neuropathy in multiple myeloma treated with thalidomide: a prospective studyR Plasmati, F Pastorelli, M Cavo, et al.
Ecancermedicalscience|February 28, 2024
<i>LuciA-15</i> - a real-world prospective study of PARP inhibitors for the treatment of patients with HER-2 negative metastatic breast cancer with germline and/or somatic mutation of BRCA genes or homologous recombination repair related genesFernando E Petracci, Cynthia Villarreal-Garza, Facundo Argañaraz, et al.
Cancers|January 23, 2024
The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative ReviewDana Narvaez, Jorge Nadal, Adrian Nervo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2016
Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG studyL Capelli, E Petracci, V Quagliuolo, et al.
ESMO Open|April 25, 2025
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trialG Schepisi, M Urbini, C Casadei, et al.
Pageof 2